# JenaValve announces strategic investment and licensing agreement with Peijia Medical

JenaValve Technology announced a strategic investment and exclusive technology licensing agreement with Peijia Medical Limited, granting Peijia exclusive rights to develop and commercialize JenaValve's Trilogy TAVR systems in Greater China, in exchange for cash, equity, and milestone payments.

- Type: Partnership
- Announced: 2022-01-18
- Where: United States
- Status: announced
- Products: Trilogy TAVR systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [JenaValve Technology](https://endata.com/companies/60411.md)
- [Peijia Medical](https://endata.com/companies/52051.md) (partner)

## Sources

- [jenavalve.com](https://jenavalve.com/agreement-w-peijia-medical-ltd/), 2022-01-18: "JenaValve Technology, Inc. today announced a strategic investment and exclusive technology licensing agreement with Peijia Medical Limited (HKEX: 9996) in China."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.